Cowen & Co. initiated coverage on IsoPlexis
$ISO
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Cowen & Co. initiated coverage of IsoPlexis with a rating of Outperform
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
2/15/2022 | $17.00 → $12.00 | Overweight | Morgan Stanley |
1/27/2022 | $20.00 → $15.00 | Outperform | SVB Leerink |
11/19/2021 | $24.00 | Outperform | Evercore ISI Group |
11/11/2021 | $17.00 → $20.00 | Outperform | SVB Leerink |
11/2/2021 | $17.00 | Outperform | SVB Leerink |
11/2/2021 | Outperform | Cowen & Co. | |
11/2/2021 | $16.00 | Overweight | Morgan Stanley |